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Antibacterial composite coatings 
of  MgB2 powders embedded in PVP 
matrix
P. Badica1*, N. D. Batalu2, M. Burdusel1, M. A. Grigoroscuta1, G. Aldica1, M. Enculescu1, 
G. Gradisteanu Pircalabioru3, M. Popa3, L. G. Marutescu3, B. G. Dumitriu4, L. Olariu4,6, 
A. Bicu4, B. Purcareanu4, L. Operti5, V. Bonino5, A. Agostino5, M. Truccato5 & M. C. Chifiriuc3
Three commercial powders of  MgB2 were tested in vitro by MTS and LDH cytotoxicity tests on 
the HS27 dermal cell line. Depending on powders, the toxicity concentrations were established 
in the range of 8.3–33.2 µg/ml. The powder with the lowest toxicity limit was embedded into 
polyvinylpyrrolidone (PVP), a biocompatible and biodegradable polymer, for two different 
concentrations. The self-replenishing  MgB2-PVP composite materials were coated on substrate 
materials (plastic foil of the reservoir and silicon tubes) composing a commercial urinary catheter. 
The influence of the PVP-reference and  MgB2-PVP novel coatings on the bacterial growth of 
Staphylococcus aureus ATCC 25923, Enterococcus faecium DMS 13590, Escherichia coli ATCC 25922, 
Pseudomonas aeruginosa ATCC 27853, in planktonic and biofilm state was assessed in vitro at 6, 24, 
and 48 h of incubation time. The  MgB2-PVP coatings are efficient both against planktonic microbes 
and microbial biofilms. Results open promising applications for the use of  MgB2 in the design of anti-
infective strategies for different biomedical devices and systems.
The opportunistic and nosocomial agents, such as ESCAPE (Enterococcus faecium, Staphylococcus aureus, 
Clostridium difficile, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacteriaceae) pathogens 
and Candida albicans represent one of the most important global threats for the public health. They have the 
ability to adhere and develop biofilms on live tissues and implanted medical devices, consequently producing 
biofilm associated  infections1. Biofilms exhibit a particular form of resistance, the phenotypic resistance or toler-
ance. They also have recalcitrance, i.e. the ability to survive in the presence of high concentrations of  antibiotics2.
The multiple negative consequences of biofilms development in the clinical sector underlines the need to 
recognize the problems contributing to poor outcomes and high costs. It also highlights the necessity of a mul-
tidisciplinary effort to prevent, combat, or eradicate biofilms. The antimicrobial strategies can be divided in 
microbiostatic/microbicidal based agents or on antipathogenic agents. The first ones involve the use of agents 
which inhibit or kill microorganisms, while the antipathogenic ones target the expression of virulence factors 
(e.g., adherence capacity, toxigenicity) and of their regulators (Quorum Sensing inhibitors)3. The antibiofilm 
strategies belong to both categories of the antimicrobial ones.
Nanotechnology and nanomaterials are of much interest for the development of new antimicrobial approaches, 
based on either novel biomaterials or on improving the biological properties of the existing ones. Currently, in a 
sustainable and eco-friendly driven approach, many studies are directed to design both clinically and environ-
mentally safe nanomaterials (NMs) for antimicrobial applications. The NMs act as antimicrobial and antibiofilm 
agents. They can have additive or synergetic effects in combinations with antibiotics or other  antimicrobials4–7. 
NMs are also useful as drug delivery for targeted release to the site of infection and as components of composites 
including stimuli-responsive coatings, or modified hybrid  materials8–10. Many physico-chemical properties, 
such as the type of the nanomaterial, size, morphology, specific surface-area-to-volume ratio, surface charge, 
concentration, behavior in biological medium and pH, stability and others are conditioning their antibiofilm 
effect. All these factors influence the contact with the biofilm matrix and biofilm embedded cells, affecting the 
release of reactive oxygen species, of antimicrobial ions or of the loaded bioactive  compounds11. NMs can be 
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modified through functionalization to increase their efficacy and  biocompatibility12. They can simultaneously 
attack multiple microbial targets, thereby the risk of emergence of resistance is low. The NMs can interfere with 
different stages of biofilm development, i.e., with single-cell adherence, multiplication, and colonization of the 
substrate, with biofilm maturation, and with biofilm dispersion. They can interact with the planktonic cells, 
inhibiting either the initial adhesion to a substrate and the dispersion, or with the biofilm matrix by facilitating 
the biofilm penetration, drug release, or further interaction with the biofilm  cells13.
Metals (silver, copper, gold, chromium), metal oxides  (Al2O3,  CeO2,  Co3O4,  Cr2O3, CuO,  In2O3,  Fe2O3, MgO, 
 Mn2O3, NiO,  Ni2O3,  SiO2,  TiO2, ZnO,  ZrO2,  Y2O3, etc.), metal hydroxides, such as Mg(OH)2, and metal halides 
nanoparticles (NPs) are among the most studied NMs for antimicrobial effects, due to their intrinsic antimicro-
bial  features11,14–18. They exhibit both microbicidal and microbiostatic effects caused by membrane lesions due to 
the direct contact with NPs and the release of free metal ions, the proteins inactivation, the nucleic acids damage, 
the release of reactive oxygen species (ROS), and stimulation of the host immune system.
The delivery of active NPs inside biofilms is possible by using different delivery systems, including polymers. 
Polyvinylpyrrolidone (PVP), also called polyvidone or povidone, is a biocompatible, non-toxic, biodegradable, 
hydrophilic polymer with good binding properties and with a stabilizing effect on suspensions and emulsions. 
PVP is recognized as safe by the Food and Drug Administration (FDA). Considering also that it has other unique 
physical and chemical features, e.g. it is chemically inert, but soluble in water and alcohol, can have different mor-
phologies, it is colorless, temperature-resistant and pH-stable, PVP is largely used for biomedical  applications19–21.
In this paper, we continue our previous studies on antimicrobial activity of  MgB2  powders22,23 and we investi-
gate their potential when embedded in PVP-based polymeric coatings for fabrication of improved plastic medical 
devices, more resistant to microbial colonization and thus, less probable to induce biofilm-associated infections. 
As substrate materials we use a flexible plastic foil of a urinary catheter reservoir and silicon tubes from the same 
commercial device. The challenges in using catheter devices and criteria for their improvement are reviewed 
in Refs.24,25. The  MgB2 compound is degradable in  water26,27 and it results that the composite coatings of PVP- 
 MgB2 are biodegradable and self-replenishing. Other different factors that recommend  MgB2 for biomedical 
application are: (i) as already mentioned, Mg is a an antimicrobial material, but also boron in the form of boric 
acid or sodium salts of boron (borax, disodium tetraborate) is an effective antiseptic, bactericidal, insecticidal, 
herbicidal and cleaning agent used in detergents (28 and therein Refs.); (ii) on the other hand, both Mg and 
boron are involved in the metabolism of humans from bone growth to wound healing and their amount in the 
body is relatively high; boron has positive effects and it is used in treatment of cancer and infections; (iii)  MgB2 
is a light weight compound with bulk density of 2.63 g/cm3 that is close to that of the bones; (iv) the mechanical 
properties of  MgB2 are similar to those of ceramic materials and of the bones; (v)  MgB2 has metallic conduction 
and when decomposes it releases positive (Mg) and negative (B) ions impacting local pH and interaction with 
negatively charged cellular wall; (v) there is a family of  MgBy  (MgB4,  MgB7,  MgB12,  MgB19) phases that may prove 
of interest to control the bioprocesses depending on application requirements.
Experimental
Physico-chemical characteristics of  MgB2 raw powders. Commercial raw powders of  MgB2 were 
produced by LTS Research Laboratories Inc (LTS), Alfa Aesar (AA), and CERAC Inc (CER). The powders have 
very different physico-chemical properties. Although results will be presented  elsewhere23, according to X-ray 
diffraction measurements and Rietveld analysis, we mention that powders were composed of the main phase 
 MgB2 and of the secondary phases MgO and  MgB4. The highest  MgB2 amount was measured in LTS (97 wt. % 
 MgB2) followed by Alfa Aesar (88 wt. %  MgB2), and Cerac (80.3 wt. %  MgB2). In the same order, the amount 
of residual unreacted metallic Mg (1.2–0 wt. %) decreases, while the amount of secondary phases MgO (1.8–
7.9 wt. %) and  MgB4 (0–11.8 wt. %) increases. The crystallite size of the powders is comparable (105–113 nm). 
In the LTS and Alfa Aesar powders, the amount of carbon (denoted y) substituting for boron in the crystal 
lattice of  MgB2 is not much different (y = 0.0011/0.0015). In the Cerac powder y is more than double (0.0039), 
considering the chemical formula Mg(B1-yCy)2. The powders have a bimodal particle size distribution. The LTS 
powders, followed by Alfa Aesar and Cerac, show high and low intensities of the peaks for the small and large 
size fractions, respectively. The large size fraction is composed of stable particle agglomerates. A higher fraction 
of small particles explains the lower flowability and a higher rate of pH increase (for powders immersed in water) 
towards saturation of LTS followed by Alfa Aesar and Cerac. The pH saturation is within a narrow range of 9.9 
and 10.1. The surface of the particles was studied by TEM and it was appreciated that surfaces are relatively clean, 
lacking oxides and impurities.
MgB2 raw powders cytocompatibility tests. The cytotoxic (loss of viable cells) effect of  MgB2 powders 
on fibroblast HS-27 (skin) cell line is assessed by observing the correlated change in cell viability (MTS  test29) 
and enzymatic activity in the culture medium (LDH test). Since the main function of fibroblasts is to maintain 
the structural integrity of connective tissue by synthesizing extracellular matrix components (particularly, type I 
collagen), the HS-27 line is a representative standard dermal cell line for testing primarily the potential of  MgB2 
for topical use and related applications. In this work the quantitative results of this test are used as input guiding 
data for the design of the  MgB2-PVP coatings compositions.
Cells were incubated with MTS (Kit: CellTiter 96 AQueous One Solution Cell Proliferation Assay, Pro-
mega) colorimetric assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)30,31. The compound 
is reduced by living cells to purple and water-soluble formazan. The conversion of MTS to formazan takes place 
under the action of enzymes (dehydrogenases) from metabolically active cells. The absorbance of formazan at 
490 nm is measured spectrophotometrically (TriStar Berthold Technologies) directly in the 96-well plates. The 
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amount of produced formazan is quantified by absorbance which is directly proportional to the number of liv-
ing cells in the culture.
Lactate dehydrogenase (LDH) is a cytosolic enzyme from the cytoplasm of any cell. Damage to the cell 
membrane causes the leak of LDH into the extracellular fluid. In vitro release of LDH provides an accurate way 
to measure cell membrane integrity and, implicitly, cell  viability32. To test the cytotoxic effect of  MgB2 on HS-27 
cell culture, cells are exposed to increasing concentrations of  MgB2 solutions. The  MgB2 solutions used in the 
MTS and LDH experiments are the same and their preparation is addressed in the next paragraphs. The release of 
LDH in the cell culture supernatant correlates with the  cytotoxicity33,34 and it is measured by a test in which two 
coupled enzymatic reactions, catalyzed by LDH and diaphorase, take place. The reactions convert a tetrazolium 
salt into a red formazan compound. Absorbance at 490 nm is measured spectrophotometrically (TriStar Berthold 
Technologies). The kit used in our experiments was CytoTox 96 Non-Radioactive Cytotoxicity Assay (Promega).
For each powder (LTS, Alpha Aesar and Cerac) two stock solutions (8.3 mg/ml and 33.3 mg/ml) in ethanol 
(99.8%) were prepared. Decimal dilutions were further used in the test. After 34 h adhesion time in 96-well 
culture plates, fibroblasts were treated with  MgB2 solutions for 48 h. The protocol involving an incubator for cell 
cultures with a humid atmosphere and 5%  CO2 at 37 °C) was applied, where the culture medium was composed 
of DMEM, 1% antibiotic/antifungal, 10% fetal bovine serum. The absorbance of the samples was related to that 
of the environmental control, the solvent control, and the cell control.
In the MTS and LDH tests, three experiments were performed using samples in triplicate. The absorbance 
ratio R of solutions with different concentrations containing treated and untreated cells in the MTS (RMTS) and 
LDH (RLDH) tests was plotted vs. concentration of  MgB2 solutions. For an increasing concentration, a decrease 
of RMTS (equivalent to less formazan produced by fewer living cells) and an increase of RLDH (equivalent to more 
LDH as a result of a lower metabolic activity due to more damaged cells) determine the cytotoxicity threshold.
Fabrication of composite  MgB2-PVP coatings. The LTS powder with the highest antimicrobial 
 activity23 was selected for fabrication of  MgB2-PVP composite coatings. Commercial polyvinylpyrrolidone 
(PVP) powder (Sigma Aldrich, the monomer N-vinylpyrrolidone, with chemical formula  C6H9NO and molar 
weight  Mw = 1,300,000 g/mol) was dissolved in ethanol at room temperature. The amount of the PVP powder 
immersed in ethanol was constant, 0.5 g, and the volume of ethanol was modified from 3 to 30 ml. Droplets of 
each solution were placed on a glass substrate (Fig. 1a). A higher uniformity of the coating and less trapped gas 
particles were noticed for a lower concentration; hence the lowest tested concentration (0.5 g PVP/30 ml etha-
nol) was selected for further processing stages. The PVP polymer is also soluble in water and this property will 
be used to release the active  MgB2 particles when in contact with bacteria.
The  MgB2 powder was introduced into as-prepared PVP-ethanol solution and mixed ultrasonically for few 
minutes, and a colloidal black solution was obtained (Fig. 2I).  MgB2 is not soluble in  alcohols35. The amount of 
the  MgB2 powder varied from 0.01 to 4 g. Droplets of the colloidal solution were placed on a glass substrate and 
Figure 1.  Coatings fabrication stages: (a) coatings of PVP with different concentrations (0.5 g of PVP in 
3–30 ml of ethanol) on a glass substrate; (b) coatings of  MgB2-PVP with different concentrations (0.01–4 g of 
 MgB2 introduced into a solution of 0.5 g PVP/30 ml ethanol) on a glass substrate (see text); (c–e) coatings on the 
polymer foil of the catheter reservoir of  PVPfoil (0.5 g PVP/30 ml ethanol),  (MgB2-PVP)foil0.25 (0.25 g  MgB2/0.5 g 
PVP/30 ml ethanol),  (MgB2-PVP)foil3 (3 g  MgB2/0.5 g PVP/30 ml ethanol), respectively; (f) (from left to right) 
pristine silicon tube of a catheter and coatings on the catheter silicon tube of  PVPtube (0.5 g PVP/30 ml ethanol), 
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dried naturally under ambient conditions (Fig. 1b). The uniformity, bubbles size and amount, and adherence of 
the coatings were observed. Two concentrations, 0.25 and 3 g per initial solution (0.5 g PVP/30 ml ethanol) were 
selected. Considering the density of PVP of 1.2 g/cm3, the selected concentrations of  MgB2 in PVP are 60 mg/ml 
and 720 mg/ml, respectively. For  MgB2 concentrations in PVP greater than 720 mg/ml, coatings are not uniform, 
showing a high level of granularity that makes them easily breakable and removable from the substrate.
The plastic foil of a reservoir and the silicon tube, both from a commercial urinary catheter, were used as 
substrates for coatings fabrication (Fig. 1c–f). Coatings of bare PVP as reference samples were also deposited. 
The composite films on the plastic foils were obtained by dip coating and subsequent drying at room temperature 
(Fig. 2II,III). They were cut into samples of 8 mm in diameter (Fig. 1c–e). The PVP-MgB2 composite covered 
both sides of the foil substrate. Coloidal solutions of  MgB2/PVP/ethanol were poured into a silicon tube and, 
after drying, a coating was obtained inside the tube (Fig. 1f). The inner/outer diameter of the tube was 4.5/6 mm. 
After coating, the tube was cut into pieces of 1 cm in length.
Coated samples were labeled as:  PVPfoil and  PVPtube (0.5 g PVP/30 ml ethanol),  (MgB2-PVP)foil0.25 and 
 (MgB2-PVP)tube0.25 (0.25 g  MgB2/0.5 g PVP/30 ml ethanol),  (MgB2-PVP)foil3 and  (MgB2-PVP)tube3 (3 g  MgB2/0.5 g 
PVP/30 ml ethanol).
The microstructure by scanning electron microscopy (SEM, Lyra 3XMU/Tescan) of the composite  MgB2-PVP 
coatings (covered with Au) on the plastic foil can be visualized in Fig. 3. The surface morphology of the com-
posite film changes with addition of a higher amount of  MgB2 powder in the coating. The presence of  MgB2 
influences drying of the coating and its roughness. While drying improves and roughness decreases for sample 
 (MgB2-PVP)foil0.25 (Fig. 3c,d) when compared to  PVPfoil (Fig. 3a,b), addition of a higher amount of  MgB2 as for 
sample  (MgB2-PVP)foil3 (Fig. 3e,f) produces a very rough and granular surface. In the sample  (MgB2-PVP)foil3 
one can actually clearly distinguish grains with plate like or irregular morphology (Fig. 3e,f) that are gathered 
into agglomerates. The morphology of the particles in the composite film is similar to that observed in the raw 
LTS  MgB2  powder23. Elemental mapping shows the presence of B and Mg, distributed uniformly at the scale 
of our observation (Fig. 3g,h). This result and short-time sonication for low energy (200 W) suggests that the 
integrity of  MgB2 was preserved during its processing in the PVP-ethanol solution for preparation of the com-
posite film. However, it is noteworthy that ultrasonication for 30 min at room temperature of  MgB2 in water 
produced through exfoliation Mg-deficient hydroxyl-functionalized nanosheets of  MgB236, while processing of 
 MgB2 in acetonitrile mixed with an ion-exchange resin leads to formation of borophane sheets (hydrogenated 
borophene, HB)37.
Figure 2.  Preparation of composite  MgB2-PVP coatings (I–III), release of active  MgB2 from the composite 
coating and its decomposition in the presence of water/aqueous solution (IV), and the antimicrobial effect 
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In vitro assay of antibacterial activity of  MgB2-PVP coatings. The antimicrobial activity of the 
composite  MgB2-PVP coatings (on foil and tubes) was tested against bacteria in planktonic and biofilms growth 
states (Staphylococcus aureus ATCC 25923, Enterococcus faecium DMS 13590, Escherichia coli ATCC 25922, 
Pseudomonas aeruginosa ATCC 27853).
In the case of planktonic bacteria, microbial suspensions of McFarland 0.5 (corresponding to 1.5 ×  108 CFU/
ml) were prepared from 24 h cultures in sterile saline solution. The obtained suspensions were further diluted 
Figure 3.  SEM images at two magnifications (× 500, × 1000) on  MgB2-PVP films coated on plastic foil: (a,b) 
sample  PVPfoil; (c,d) sample  (MgB2-PVP)foil0.25; (e,f) sample  (MgB2-PVP)foil3. Secondary electron image from (g) 
presents a detail at high magnification (× 15,000) of sample  (MgB2-PVP)foil3, while (h) is a red–green–blue image 
obtained by overlapping the elemental EDS maps of Mg and B measured on image from (g).
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1:100 in broth. Each composite  MgB2-PVP sample was introduced into a well of a 24-well plate. The plate was 
inoculated with the prepared microbial suspension (750 µl). The final inoculum size was of 5 ×  105 CFU/ml for 
each tested coating. Untreated microbial cultures and sterile broth wells served as positive and negative controls. 
The inoculated 24 well-plates were incubated at 37 °C, in aerobic conditions for 6 h, 24 h, and 48 h. After incuba-
tion for the respective time intervals, the density of the microbial broth culture was determined by plating serial 
ten-fold dilutions prepared in sterile saline onto PCA (Plate Count Agar) and counting the number of colonies 
developed at different dilutions. Results were further used to determine the number of colonies forming units 
(CFU/ml).
In the case of biofilms, coatings were placed in contact with an inoculum of 5 ×  105 CFU/ml obtained from 
each microbial strain and incubated for 6, 24, and 48 h. After incubation, each material was carefully washed 
to remove the non-adherent bacteria and sonicated in sterile saline solution to disperse the biofilm, and serial 
decimal dilutions were seeded on agar plates to determine the CFU/ml as presented above.
All assays were done in triplicate.
Results
Cytocompatibility of  MgB2 powders. All dilutions (66–333 µg/ml) of stock solution with concentration 
33.3 mg/ml and for the three investigated  MgB2 powders (LTS, Alfa Aesar and Cerac) have shown cytotoxicity 
on the H27 cell line. The effect of dilutions with smaller concentrations (0.83–83 µg/ml) prepared from the stock 
solution 8.3 mg/ml are presented in Fig. 4. Concentrations of  MgB2 solutions below 8.3, 33.2, and 33.2 µg/ml 
for the powders LTS, Alfa Aesar, and Cerac are compatible with the metabolism of fibroblasts without a toxic 
impact. In other experiments with different  cells38 the toxicity limit was in the range of 50–100 µg/ml. The LTS 
powder has a lower biocompatibility than Alfa Aesar and Cerac powders.
Higher cytotoxicity of LTS comparative to the other  MgB2 investigated powders can be inferred from its low 
tendency to form large agglomerates, clean particle surfaces, high amount of  MgB2 phase, and high pH-increase 
 rates23. Different activity of different  MgB2 powders enables the possibility of a time and space-controlled reac-
tion of  MgB2 with biological medium, depending on the application requirements, so that the toxic effect is 
minimized, and antibacterial impact is maximized.
For design purposes of the  MgB2-PVP coatings, apart from the as-evaluated cytotoxicity concentrations, 
we considered the minimum inhibitory concentrations for the growth in the presence of LTS, Alfa Aesar and 
Cerac  MgB2 powders of different reference microbes (Staphylococcus aureus ATCC 25923, Staphylococcus aureus 
ATCC 6538, Pseudomonas aeruginosa ATCC 27853, Escherichia coli ATCC 25922, and Candida albicans ATCC 
10231) in the planktonic (MIC) and biofilm (MICB) states reported in Ref.23. Namely, the MIC and MBIC values 
ranged between 0.31 and 1.25 mg/ml and between 0.039 and 0.62 mg/ml, respectively. The highest antimicrobial 
activity was found for LTS and the lowest for Cerac. The  MgB2 powders were active also against planktonic cells 
and biofilms of 29 methicillin resistant clinical S. aureus isolates and 33 vancomycin resistant E. faecium/faecalis 
strains collected from clinical souces. The MIC values of 0.15–2.5 mg/ml were determined for different fungi 
collected from the heritage buildings and  objects38.
Antibacterial activity of  MgB2-PVP composite coatings. The influence of PVP and  MgB2-PVP coat-
ings on the bacterial growth in planktonic state (in the liquid culture medium) and biofilm state (adhered on the 
surface of plastic foil or silicon catheter) was assessed at 6, 24, and 48 h of bacterial strains incubation with the 
tested samples. Results are presented in Figs. 5 and 6.
The general trend was that the  MgB2-PVP samples exhibited an evident inhibitory activity on the planktonic 
growth of all tested strains, starting with 6 h of incubation, exacerbating after 24 h, and maintaining it at 48 h 
(Figs. 5, 6).
The inhibitory effect of the planktonic growth was more intense in the case of the samples  (MgB2-PVP)foil3 
containing the highest concentration of  MgB2. In the case of the bacterial cells adhered on the surface of the 
functionalized plastic samples, the anti-biofilm effect was strain specific, but however, less evident than in the case 























































Figure 4.  The absorbance ratio R in MTS and LDH cytotoxicity tests on HS27 cell line for dilutions prepared 
from stock solutions of 8.3 mg/ml of three types of  MgB2 powders.
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The same sample inhibited the P. aeruginosa and S. aureus biofilm at 24 h and 48 h, respectively. In the case of 
E. faecium, all samples inhibited the initial cells adherence to the plastic foil, quantified after 6 h of incubation, 
and the  (MgB2-PVP)foil3 exhibited also a slight inhibitory effect against the 24 h biofilm (Fig. 5). The comparative 
behaviour of planktonic and adhered cells developed in the presence of  MgB2-functionalized plastic-foil samples 
suggests that the coatings exhibit their antimicrobial effect mostly by releasing the  MgB2 in the active form.
The rate of the bacterial strains growth in the presence of the  MgB2-functionalized silicon tubes was different 
from that recorded on the plastic samples, with no significant inhibition of the planktonic growth, except a slight 
decrease of the number of the viable cells of S. aureus after 24 h of incubation and of E. coli and E. faecium after 
48 h of incubation. No significant differences between the PVP and  MgB2-PVP samples (Fig. 6) were noted. In the 
case of the bacterial cells adhered on the surface of the  MgB2-functionalized silicon tubes, the  (MgB2-PVP)tube3 
inhibited the P. aeruginosa biofilm development, with the anti-biofilm effects intensity decreasing in time from 
6 to 48 h. The  (MgB2-PVP)tube0.25 sample has shown a slight tendency for inhibition of the S. aureus biofilm 
development, the effect being noticable after 6 h of incubation. All samples slightly inhibited the development 
of E. faecium at all three incubation times. As for S. aureus, the effect is stronger at 6 h.
Results indicate that  MgB2-containing samples on foils are more active than the coatings on silicon tubes. 
To understand it, further research is necessary. Among the possible reasons there could be how the shape of 
the sample influences the contact with the cell browth, the release of  MgB2 and its interaction with the cells. A 
second aspect that could play a role is the fact that adherence of the coatings on the silicon tube is poor when 
compared to that on the foil. This is especially problematic for coatings with a high concentration of  MgB2, i.e. 
for the samples  (MgB2-PVP)tube3.
Discussion
Considering the data presented in “Cytocompatibility of  MgB2 powders” it results that selected  MgB2 powder 
for coatings fabrication, LTS, has the lowest toxicity limit, corresponding to the highest cytotoxicity. At the same 
time, this powder is the most active one from the viewpoint of antimicrobial efficiency, i.e. the MIC and MBIC 
values are the  lowest23. To understand the context of our antimicrobial assessment from “Antibacterial activity of 
Figure 5.  The number of viable microbial cells in  log10(CFU/ml) for samples in the form of coatings on the 
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 MgB2-PVP composite coatings” and to provide some guiding lines in designing  MgB2-PVP coatings for future 
different applications, we present some useful details in the following paragraphs.
The thickness of the coatings was estimated from optical measurements at ~ 200 µm. The volume of the 
coatings for the foil and tube samples was 0.02 and 0.028 ml, respectively. When using 0.25 g and 3 g of  MgB2 to 
fabricate the samples, this results into a concentration of 0.6 and 7.2 mg/ml of the powder in the volume of PVP 
dissolved in ethanol (density of PVP was taken as 1.2 g/cm3 and density of  MgB2 as 2.6 g/cm3). Rescaling for the 
volume of the coating on the foil, the  (MgB2-PVP)foil0.25 and  (MgB2-PVP)foil3 samples contain 9.75 and 38.2 mg 
of  MgB2, respectively. A similar calculation for the  (MgB2-PVP)tube0.25 and  (MgB2-PVP)tube3 samples gives the 
values 13.65 and 53.5 mg, respectively.
To obtain a correct intepretation of our data, we should also take into consideration the PVP behavior in 
water. To this purpose, a bulk rectangular piece of PVP (0.5 cm × 0.5 cm × 0.1 cm) was prepared by casting a 
viscous solution of PVP in ethanol and subsequent drying in the air. The PVP sample with a volume 0.025 ml 
was introduced in water (50 ml). It dissolved in 3 h at room temperature, without steering. The dissolution rate 
of PVP in water is 0.0083 ml/h.
In the in vitro antimicrobial tests addressed in “Antibacterial activity of  MgB2-PVP composite coatings”, 
samples were fully immersed in 750 µl of culture medium. The incubation time of 6, 24, and 48 h is higher 
than the dissolution time of PVP in water of 3 h. One also observes that the volume of the bulk PVP sample 
(0.025 ml) is comparable to that of the coatings (0.02 and 0.028 ml on the foil and on the tube, respectively). This 
suggests that the entire amount of  MgB2 powder in the coating was available to interact with the bacterial cells 
from the broth. Hence, the concentration of  MgB2 in the cell broth was as follows: 13, 50.9, 18.2, and 71.3 mg/
ml for samples  (MgB2-PVP)foil0.25,  (MgB2-PVP)foil3,  (MgB2-PVP)tube0.25, and  (MgB2-PVP)tube3, respectively. These 
values are comparable, or they are one order of magnitude higher that the MIC and MBIC values mentioned 
in “Cytocompatibility of  MgB2 powders”. They are also about three orders of magnitude larger than the toxicity 
limit of the powders. Interaction of  MgB2 with water, culture media, or body fluids is complex and needs further 
investigations. Some information for Mg, MgO, Mg(OH)2 and  MgB2 was reported in Refs.26,27,36,39–41. The involved 
processes develop in multistep sequences specific for each phase. Moreover, the reaction products, kinetic factors, 
and environmental conditions will ensure, or not, the background for antibacterial activity evolution with time. 
For example, the reaction of  MgB2 with water leads to formation of Mg(OH)2, while boron in water forms boric 
acid. Due to low solubility in water, Mg(OH)2 can passivate the surface of  MgB2 decreasing its efficiency. However 
Figure 6.  The number of viable of microbial cells in  log10(CFU/ml) for samples in the form of coatings on the 
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in physiologically relevant solutions Mg(OH)2 was found to  dissociate32. On the other hand, in the reaction 
between  MgB2 and water, the  H2-gas is released, and it can disrupt the passivating layer and can clean the surface 
of the  MgB2 particle. The overlapping of the processes, some of them with possibly opposite contributions, can 
explain the non-linear dependence of the bioactivity with time observed in our experiments from “Antibacterial 
activity of  MgB2-PVP composite coatings”, but one should also consider the decreasing amount of  MgB2, which 
is consumed in the interaction with cells and environment. Therefore, the current discussion and provided 
numbers draw attention on the necessity to properly design the coatings considering each specific application.
The mechanisms by which our composite coatings develop the antimicrobial effect deserves further targeted 
studies. In general, for nanomaterials the  mechanisms11,42 are related to their influence on production of reactive 
oxygen species (ROS) (and in some cases of reactive nitrogen species RNA) through a catalytic action described 
by Haber/Weiss- and Fenton- type  reactions13,43, on electrostatic interaction that can impact the disruption/
damage of the membrane integrity and potential so that metabolic functions of the cells are affected, and on 
the changes in the local environmental conditions e.g. through modification of aeration and pH. Depending on 
materials, cells, and environment there are specific features. For our composite coatings, PVP disolves in water, 
 MgB2 is released and it becomes active interacting with the aqueous  environment44 and the cells (Fig. 2IV). PVP 
is inert in respect to its antimicrobial  activity45. The possibility of exfoliation of  MgB2 with formation of nano 
sheet materials such as hydroxyl functionalized Mg-deficient  MgB236 or borophane (HB)37 may provide extra 
positive specific value in fighting the microbes: the 2D borophene-type materials are shown to have catalytic 
 properties46 that can impact directly or indirectly also bioprocesses. Furthermore, another 2D material, namely 
the graphene oxide emerged as an effective antimicrobial  material47 and, through similarities and extrapolation, 
one may expect that also the 2D nano boron-type materials derived from  MgB2 will play an important role as 
antimicrobial materials. However, at present, there are no experiments performed in this direction. In summary, 
different ionic species are generated because of the  MgB2 presence and they are at the origin of the developing 
reactions necessary for the antimicrobial effect (Fig. 2V).
The antimicrobial activity of  MgB2 assessed in our work revealed good efficiency against selected bacteria, 
e.g. for planktonic growth (Fig. 5) one may observe a decrease for  (MgB2-PVP)foil3 of 7log/24 h against E. coli, 
8log/24 h against P. aeruginosa, 8log/24 h against S. aureus, and 5log/24 h against E. faecium. Literature present 
other effective composite antibacterial materials, such as AgBr/nPVP45 with a 5log/2 h against E. coli, and a lower 
concentration of the active substance (however, no citotoxicity data are available for comparison). In Ref.48 was 
reported a decrease of CFU/ml for nitric oxide (NO) of 8 log/24 h against E. coli/A. baumannii/S. aureus. In 
Ref.49 for copper (Cu) the decrease of CFU/ml was of 4log/24 h against E. coli/S. aureus. In Ref.50 was shown 
for silver (Ag) a decrease of CFU/ml of 5log/1.5 h against E. coli/S. aureus. It is important to note that a direct 
comparison between reported data is not entirely possible, as the assessment procedures are slightly different, 
the control samples do not start from the same level of cells population, and samples are different in shape and 
size and they target different applications.
Conclusion
In vitro MTS and LDH cytotoxicity tests of the  MgB2 activity on the HS27 dermal cell line indicated a toxicity 
limit in the range of 8.3–33.2 µg/ml depending on the powder type. Three powders were tested and the most 
active was LTS. According to  literature23 this powder shows the highest amount of  MgB2 phase, impurity-free 
particle surfaces, the largest fraction of the particle size in the nano-range and the highest rate of pH increase. 
The LTS powder was further used for fabrication of  MgB2–PVP coatings on plastic elements from a commercial 
urinary catheter. The as-prepared self-replenishing and biodegradable  MgB2–PVP composite coatings with two 
compositions were tested at 6, 24, and 48 h of incubation time against the bacterial growth of Staphylococcus 
aureus ATCC 25923, Enterococcus faecium DMS 13590, Escherichia coli ATCC 25922, Pseudomonas aeruginosa 
ATCC 27853. Strains were in the planktonic and biofilm growth states. The coatings were efficient both against 
planktonic microbes and microbial biofilms when applied on plain, flexible plastic foils. Results are promising 
and recommend  MgB2 for designing efficient anti-infective solutions for various biomedical devices and systems.
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